P2X7 PET Radioligand
P2X7 receptors
inflammation marker
lung tumor
purinergic receptors
Journal
Journal of nuclear medicine : official publication, Society of Nuclear Medicine
ISSN: 1535-5667
Titre abrégé: J Nucl Med
Pays: United States
ID NLM: 0217410
Informations de publication
Date de publication:
07 2019
07 2019
Historique:
received:
29
10
2018
accepted:
10
12
2018
pubmed:
19
1
2019
medline:
31
3
2020
entrez:
19
1
2019
Statut:
ppublish
Résumé
Site-specific imaging agents play a key role in tumor targeting, but only a few agents are currently available for inflammation targeting. Since the P2X7 receptor (P2X7R) is a promising molecular target for inflammation, we evaluated the potential value of the
Identifiants
pubmed: 30655332
pii: jnumed.118.222547
doi: 10.2967/jnumed.118.222547
pmc: PMC6604685
doi:
Substances chimiques
Pyridines
0
Receptors, Purinergic P2X7
0
pyridine
NH9L3PP67S
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
930-936Informations de copyright
© 2019 by the Society of Nuclear Medicine and Molecular Imaging.
Références
Nature. 2002 Dec 19-26;420(6917):860-7
pubmed: 12490959
Nature. 2006 Dec 14;444(7121):860-7
pubmed: 17167474
Cell. 2010 Mar 19;140(6):918-34
pubmed: 20303880
Eur J Nucl Med Mol Imaging. 2011 Feb;38(2):352-7
pubmed: 21085954
J Cereb Blood Flow Metab. 2012 Jan;32(1):1-5
pubmed: 22008728
Nat Chem. 2013 Nov;5(11):941-4
pubmed: 24153372
Pharmacol Rev. 2014 Jul;66(3):638-75
pubmed: 24928329
J Labelled Comp Radiopharm. 2014 Jun 30;57(8):509-16
pubmed: 24995673
Cancer Res. 2015 Feb 15;75(4):635-44
pubmed: 25542861
Cancer Res. 2015 Mar 1;75(5):835-45
pubmed: 25564520
Semin Cancer Biol. 2015 Dec;35 Suppl:S185-S198
pubmed: 25818339
ACS Med Chem Lett. 2015 Apr 24;6(6):671-6
pubmed: 26101572
Science. 2015 Jul 17;349(6245):316-20
pubmed: 26185250
Adv Protein Chem Struct Biol. 2016;104:39-79
pubmed: 27038372
J Nucl Med. 2016 Sep;57(9):1436-41
pubmed: 27199364
Glia. 2016 Oct;64(10):1772-87
pubmed: 27219534
J Nucl Med. 2017 Feb;58(2):300-306
pubmed: 27561878
J Nucl Med. 2017 Mar;58(3):458-465
pubmed: 27765863
EJNMMI Res. 2017 Dec;7(1):31
pubmed: 28374288
Int J Mol Sci. 2017 Apr 11;18(4):
pubmed: 28398245
Theranostics. 2017 Mar 24;7(6):1422-1436
pubmed: 28529627
J Neuroinflammation. 2017 Dec 22;14(1):259
pubmed: 29273052
Bioorg Med Chem Lett. 2018 May 15;28(9):1603-1609
pubmed: 29628324
Sci Rep. 2018 Apr 26;8(1):6580
pubmed: 29700413
J Nucl Med. 1995 Jul;36(7):1301-6
pubmed: 7790960